Skip to main content

Publications

108 publications

Active

3 grants
  • MPI
    T32 Urologic Oncology Research Training Grant
    NCI · 1999–2030 · via NIH RePORTER
  • MPI
    Project 2: Overcoming Microenvironment-Mediated Resistance to AR Pathway Inhibition in High-Risk Prostate Cancer
    NCI · 2001–2027 · via NIH RePORTER
  • MPI
    PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapy
    NCI · 2021–2027 · via NIH RePORTER
Completed grants (2)
  • MPI
    Project 3: Defining the appropriate context for targeting kinase signaling in combination with androgen receptor blockade to enhance therapeutic response in metastatic prostate cancer
    NCI · 2017–2023 · via NIH RePORTER
  • PI
    Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
    NCI · 2014–2020 · via NIH RePORTER